A phase III trial of ponesimod in patients with severe chronic plaque psoriasis.
Phase of Trial: Phase III
Latest Information Update: 22 Jul 2013
At a glance
- Drugs Ponesimod (Primary)
- Indications Plaque psoriasis
- Focus Registrational; Therapeutic Use
- 22 Jul 2013 Commencement of this trial is on hold until a second generation S1P modulator has been assessed by the company.
- 20 Dec 2012 New trial record